Moreover, Xu et al. [36] have evaluated CE2 expression in different tumors and have shown that 66% of tumor tissues expressed CE2 and that conversion of CPT-11 to SN-38 was correlated with the enzyme expression. The gene discussed is CES2; the disease is neoplasm.